The field is increasingly facing demands from payers, parents, policymakers, and the public at large for “evidence-based practices (EBP)” which can reliably produce practical and cost-effective interventions, therapies and medications that will:
reduce substance use and its negative consequences among those who are abusing or dependent,
reduce the likelihood of relapse for those who are recovering, and
reduce risks for initiating drug use among those not yet using.
Source: Dennis, Michael, 2005 NIDA Blue Ribbon Panel on Health Services Research
© Doreen A. Cavanaugh, Ph.D.
November 12, 2009